Researchers at NYU Langone’s Fresco Institute for Parkinson’s and Movement Disorders conduct clinical trials to advance the understanding and treatment of Parkinson’s disease and movement disorders.

For more information about research at the Fresco Institute, call our research team at 646-501-4367 or email Pdresearch@NYULangone.org.

Mechanisms of Parkinson’s Disease and Associated Disorders

GBA1 Mutations and Parkinson’s Disease
Principal investigator: Giulietta M. Riboldi, MD, PhD

An Observational Longitudinal Oligo-Center Study to Define Clinical
Principal investigator: Horacio Kaufmann, MD

Synucleinopathy and Constipation: A Prospective Observational Study of the Physiology of Constipation in Comparison to Chronic Idiopathic Constipation
Principal investigator: Rita M. Knotts, MD

The New York Movement Disorder (NYMD) Study
Principal investigator: Steven J. Frucht, MD

New York Movement Disorders Genomic Study
Principal investigator: Giulietta M. Riboldi, MD, PhD

Study in Parkinson’s Disease of Exercise Phase 3 Clinical Trial: SPARX3
Principal investigator: Patrick Drummond, MD

Therapeutic Trials in Parkinson’s Disease and Other Movement Disorders

Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy Safety and Tolerability of 36 Weeks of Treatment with NLY01 in Early-Stage Parkinson’s Disease
Principal investigator: Andrew S. Feigin, MD

Observational and Biomarker Studies in Parkinson’s Disease

The Parkinson’s Progression Markers Initiative (PPMI) 2.0 Clinical—Establishing a Deeply Phenotyped PD Cohort
Principal investigator: Giulietta M. Riboldi, MD, PhD

Epigenetic Characterization of Immune Cells in Parkinson’s disease and Prodromal Stages (EpiFEN PD) Study
Principal investigator: Giulietta M. Riboldi, MD, PhD

Genetic Screening Outcomes in Movement Disorders
Principal investigator: Giulietta M. Riboldi, MD, PhD

Prodromal and Early Parkinsonism Alpha-Synuclein Study
Principal investigator: Un J. Kang, MD